| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K41334119 | CTRPv2 | pan-cancer | AAC | 0.17 | 0.03 |
| mRNA | Ko-143 | CTRPv2 | pan-cancer | AAC | 0.082 | 0.03 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.069 | 0.03 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.07 | 0.03 |
| mRNA | selumetinib:UNC0638 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.078 | 0.03 |
| mRNA | BRD-K52037352 | CTRPv2 | pan-cancer | AAC | 0.088 | 0.03 |
| mRNA | Tipifarnib | GDSC1000 | pan-cancer | AAC | 0.075 | 0.03 |
| mRNA | phloretin | CTRPv2 | pan-cancer | AAC | 0.074 | 0.04 |
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | 0.07 | 0.04 |
| mRNA | WZ8040 | CTRPv2 | pan-cancer | AAC | 0.083 | 0.04 |